- Home
- OBIO vs MGYR Comparison
OBIO vs MGYR Comparison
Compare OBIO & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- MGYR
- Stock Information
- Founded
- OBIO 2017
- MGYR 1922
- Country
- OBIO United States
- MGYR United States
- Employees
- OBIO N/A
- MGYR N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- MGYR Savings Institutions
- Sector
- OBIO Health Care
- MGYR Finance
- Exchange
- OBIO Nasdaq
- MGYR Nasdaq
- Market Cap
- OBIO 118.8M
- MGYR 98.9M
- IPO Year
- OBIO N/A
- MGYR 2006
- Fundamental
- Price
- OBIO $3.29
- MGYR $17.00
- Analyst Decision
- OBIO Strong Buy
- MGYR
- Analyst Count
- OBIO 5
- MGYR 0
- Target Price
- OBIO $14.20
- MGYR N/A
- AVG Volume (30 Days)
- OBIO 303.1K
- MGYR 9.1K
- Earning Date
- OBIO 08-11-2025
- MGYR 07-24-2025
- Dividend Yield
- OBIO N/A
- MGYR 2.12%
- EPS Growth
- OBIO N/A
- MGYR 35.31
- EPS
- OBIO N/A
- MGYR 1.57
- Revenue
- OBIO $2,886,000.00
- MGYR $35,533,000.00
- Revenue This Year
- OBIO $20.47
- MGYR N/A
- Revenue Next Year
- OBIO $11.45
- MGYR N/A
- P/E Ratio
- OBIO N/A
- MGYR $10.83
- Revenue Growth
- OBIO 30.23
- MGYR 18.29
- 52 Week Low
- OBIO $2.37
- MGYR $11.96
- 52 Week High
- OBIO $8.30
- MGYR $19.04
- Technical
- Relative Strength Index (RSI)
- OBIO 60.31
- MGYR 57.61
- Support Level
- OBIO $3.05
- MGYR $16.50
- Resistance Level
- OBIO $3.24
- MGYR $17.20
- Average True Range (ATR)
- OBIO 0.16
- MGYR 0.29
- MACD
- OBIO 0.03
- MGYR -0.04
- Stochastic Oscillator
- OBIO 93.75
- MGYR 71.43
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.